147 results
8-K
EX-99.1
LCTX
Lineage Cell Therapeutics, Inc.
9 May 24
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:10pm
commitment by Genentech for the benefit of the OpRegen program. We believe this agreement will enable our partners to take advantage of our cell
8-K
EX-10.1
lbujhymcy omp9yv7
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
8-K
EX-99.1
1z4pvovm0lq1zpmj6epi
10 Aug 23
LINEAGE CELL THERAPEUTICS REPORTs SECOND QUARTER 2023 FINANCIAL
4:10pm
8-K
EX-99.1
9xl6ydlx
11 May 23
LINEAGE CELL THERAPEUTICS REPORTs FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:10pm
8-K
EX-99.1
b7r7xl
10 Nov 22
LINEAGE CELL THERAPEUTICS REPORTs THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:11pm
8-K
EX-99.1
3oe78nysgq6p xngfb
20 Dec 21
Entry into a Material Definitive Agreement
6:06am
S-8
EX-99.2
dhm15
28 Sep 21
Registration of securities for employees
4:15pm
S-8
EX-99.3
abr 11sjl74vb42ze52x
28 Sep 21
Registration of securities for employees
4:15pm